Ownes & Minor (OMI) Misses Q4 EPS by 11c, Revenue Beats; Guides FY23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Owens & Minor Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023 6:05 AM ESTPatient Direct Q4 revenue up 135%, or 10.3% on an adjusted basis for the Apria Acquisition 2022 full year operating cash flow of $325 million Operating Model Realignment Program expected to improve profitability & cash flow by approximately: $30 million of Adjusted Operating Income in 2023 $200 million of Adjusted Operating Income by 2025 $250-$400 million of working capital benefit by 2025
RICHMOND, Va.--(BUSINESS WIRE)-- Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the fourth quarter and the year ended December 31, 2022, as summarized in the table... More
